Univariate prognostic models depending on laboratory values, supportive therapies, CAT scan patterns and first absolute cyclophosphamide dosage. Additional plasmapheresis, early cyclophosphamide administration (≤10 days to ILD diagnosis) and an absolute first cyclophosphamide dose ≤800 mg were associated with improved overall survival in ILD patients treated with cyclophosphamide on ICU